Filter News
Area of Research
- Biological Systems (1)
- Biology and Environment (26)
- Clean Energy (14)
- Computational Biology (1)
- Computational Engineering (1)
- Fusion and Fission (6)
- Fusion Energy (1)
- Isotopes (4)
- Materials (11)
- Materials for Computing (1)
- National Security (7)
- Neutron Science (11)
- Nuclear Science and Technology (7)
- Supercomputing (46)
News Type
News Topics
- (-) Advanced Reactors (18)
- (-) Big Data (29)
- (-) Biomedical (45)
- (-) Frontier (37)
- (-) Net Zero (11)
- 3-D Printing/Advanced Manufacturing (79)
- Artificial Intelligence (74)
- Bioenergy (73)
- Biology (79)
- Biotechnology (17)
- Buildings (30)
- Chemical Sciences (50)
- Clean Water (15)
- Climate Change (69)
- Composites (15)
- Computer Science (137)
- Coronavirus (34)
- Critical Materials (12)
- Cybersecurity (31)
- Decarbonization (62)
- Education (4)
- Element Discovery (1)
- Emergency (2)
- Energy Storage (69)
- Environment (136)
- Exascale Computing (33)
- Fossil Energy (5)
- Fusion (41)
- Grid (38)
- High-Performance Computing (68)
- Hydropower (5)
- Isotopes (43)
- ITER (4)
- Machine Learning (34)
- Materials (99)
- Materials Science (93)
- Mathematics (5)
- Mercury (9)
- Microelectronics (2)
- Microscopy (36)
- Molten Salt (3)
- Nanotechnology (42)
- National Security (51)
- Neutron Science (96)
- Nuclear Energy (77)
- Partnerships (42)
- Physics (51)
- Polymers (20)
- Quantum Computing (28)
- Quantum Science (55)
- Renewable Energy (2)
- Security (21)
- Simulation (37)
- Software (1)
- Space Exploration (15)
- Statistics (2)
- Summit (50)
- Sustainable Energy (74)
- Transformational Challenge Reactor (7)
- Transportation (52)
Media Contacts
OAK RIDGE, Tenn., March 20, 2019—Direct observations of the structure and catalytic mechanism of a prototypical kinase enzyme—protein kinase A or PKA—will provide researchers and drug developers with significantly enhanced abilities to understand and treat fatal diseases and neurological disorders such as cancer, diabetes, and cystic fibrosis.
OAK RIDGE, Tenn., March 4, 2019—A team of researchers from the Department of Energy’s Oak Ridge National Laboratory Health Data Sciences Institute have harnessed the power of artificial intelligence to better match cancer patients with clinical trials.
While studying the genes in poplar trees that control callus formation, scientists at Oak Ridge National Laboratory have uncovered genetic networks at the root of tumor formation in several human cancers.
The Department of Energy’s Oak Ridge National Laboratory is collaborating with industry on six new projects focused on advancing commercial nuclear energy technologies that offer potential improvements to current nuclear reactors and move new reactor designs closer to deployment.
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.
“Made in the USA.” That can now be said of the radioactive isotope molybdenum-99 (Mo-99), last made in the United States in the late 1980s. Its short-lived decay product, technetium-99m (Tc-99m), is the most widely used radioisotope in medical diagnostic imaging. Tc-99m is best known ...
The field of “Big Data” has exploded in the blink of an eye, growing exponentially into almost every branch of science in just a few decades. Sectors such as energy, manufacturing, healthcare and many others depend on scalable data processing and analysis for continued in...
A team of researchers from Oak Ridge National Laboratory has been awarded nearly $2 million over three years from the Department of Energy to explore the potential of machine learning in revolutionizing scientific data analysis. The Advances in Machine Learning to Improve Scient...